SomaLogic® was founded in 2000 by Larry Gold, with the goal of improving the well-being and quality of life of every individual by transforming how diseases were detected and diagnosed. Building on the previous decade of aptamer research, SomaLogic scientists have developed a new proteomics technology that overcomes the significant challenges of current technologies, and has multiple applications across the biological and medical sciences. Our mission is to leverage our proprietary technology to discover, develop and commercialize revolutionary new life science research tools and breakthrough clinical diagnostic products that will transform healthcare. See more at: https://somalogic.com/About-Us
The Gold Lab at the University of Colorado Boulder was established in 1971 by Dr. Larry Gold upon his arrival at the Department of Molecular, Cellular, and Developmental Biology. Starting with basic research on bacteria and bacteriophage, the lab shifted its focus to human disease following the invention of the SELEX process in 1989. The Gold Lab today focuses on the utilization of biological and information technology to improve healthcare.